Rhythm Pharmaceuticals, Inc.
RYTMCIK 0001649904 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
4,445 bought / 2,150 sold
net +2,295 sh · −$237.4K
- buys
- 1
- sells
- 1
- insiders active
- 1
Filing tape
Filed Thu, Jul 2, 2026
- +2,295 sh · $237.4K
Garfield Alastair — Chief Scientific Officer
- Exercised4,445Common Stock→ 12,208 held
- Withheld for tax2,150Common Stock@ $110.41→ 10,058 held
- Exercised4,445Restricted Stock Units→ 8,888 held
Insiders on this tape
- Garfield AlastairChief Scientific Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.